Modalis Therapeutics Corporation
Records under this name other than the patents Modalis Therapeutics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 2 of 2 · Back to Modalis Therapeutics Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,530,396 | Modified CAS9 Protein, and Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,439,692 | Method of Treating Diseases Associated with MYD88 Pathways Using CRISPR-Gndm System Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |